The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world use of supportive medications to prevent and manage key adverse events during first-line (1L) treatment of metastatic pancreatic adenocarcinoma (mPDAC) with FOLFIRINOX (FFX), FFX without 5FU bolus, and gemcitabine+nab-paclitaxel (GnP).
 
Syvart Dennen
Consulting or Advisory Role - Ipsen
Research Funding - Ipsen
 
Marty Masek
Consulting or Advisory Role - Ipsen
Research Funding - Ipsen
 
Paul Cockrum
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Ravi Paluri
Honoraria - Exelixis; Ipsen; Seagen
Consulting or Advisory Role - Exelixis; Ipsen; Seagen
Speakers' Bureau - Ipsen; Seagen